Cleared Traditional

Bunkerhill AVC (K243229) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K243229 · BunkerHill Health · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2025
Decision
111d
Days
Class 2
Risk

K243229 is an FDA 510(k) clearance for the Bunkerhill AVC. Classified as System, X-ray, Tomography, Computed (product code JAK), Class II - Special Controls.

Submitted by BunkerHill Health (San Francisco, US). The FDA issued a Cleared decision on January 27, 2025 after a review of 111 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1750 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all BunkerHill Health devices

Submission Details

510(k) Number K243229 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 08, 2024
Decision Date January 27, 2025
Days to Decision 111 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
4d slower than avg
Panel avg: 107d · This submission: 111d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code JAK System, X-ray, Tomography, Computed
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1750
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - JAK System, X-ray, Tomography, Computed

All 421
Devices cleared under the same product code (JAK) and FDA review panel - the closest regulatory comparables to K243229.
BodyTom 64
K242811 · Neurologica Corporation, A Subsidiary of Samsung · Mar 2025
Brainomix 360 e-Lung
K242411 · Brainomix Limited · Feb 2025
NAEOTOM Alpha.Peak/ NAEOTOM Alpha
K243523 · Siemens Medical Solutions USA, Inc. · Feb 2025
uCT 550
K241166 · Shanghai United Imaging Healthcare Co., Ltd. · Jan 2025
SpotLight/SpotLight Duo with Low Dose Lung Cancer Screening Option
K241200 · Arineta , Ltd. · Jan 2025
uCT 780
K241079 · Shanghai United Imaging Healthcare Co., Ltd. · Jan 2025